{"id":"W2549800333","doi":"10.1158/0008-5472.can-16-1873","title":"PolyI:C and CpG Synergize with Anti-ErbB2 mAb for Treatment of Breast Tumors Resistant to Immune Checkpoint Inhibitors","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Trastuzumab; Immune system; Cancer research; Monoclonal antibody; Immunotherapy; Breast cancer; Medicine; Immunology; CD8; Cancer; CpG site; Acquired immune system; Innate immune system; Immune checkpoint; Antibody; Biology; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001808846,0.0005152532,0.0004072388,0.0003451844,0.000104189,0.0002021788,0.000240675,0.0003202247,0.001578826],"category_scores_gemma":[0.00009656401,0.0001207861,0.0002447944,0.0001932349,0.0001832748,0.0001401571,0.0001820404,0.000579665,0.0004164794],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002540985,"about_ca_system_score_gemma":0.0002840577,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006020551,"about_ca_topic_score_gemma":0.001428287,"domain_scores_codex":[0.9998832,0.00002943783,0.000007776332,0.00001619559,0.00002966783,0.00003371055],"domain_scores_gemma":[0.9999318,0.00001244388,0.00001434511,0.000009081608,0.000006822815,0.00002551542],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0016515,0.0009958892,0.0002283674,0.000146722,0.00003446889,0.0001130662,0.00002366853,0.0005077291,0.9793025,0.0001050556,0.0003858351,0.01650526],"study_design_scores_gemma":[0.0008721963,0.01362707,0.006571974,0.00002105604,0.0001047082,0.000631165,0.00002341664,0.003992406,0.9655439,0.00005899414,0.00853805,0.0000149562],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9891992,0.004249304,0.002004832,0.0001822303,0.0001461194,0.0002933224,0.0002592682,0.000143246,0.00352258],"genre_scores_gemma":[0.9926813,0.0015572,0.002244519,0.00009687188,0.00004624566,0.0002060112,0.0003352849,0.00002371404,0.002808668],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001578826,"threshold_uncertainty_score":0.005281746,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04022546538509793,"score_gpt":0.3621033141185209,"score_spread":0.321877848733423,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}